BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1662 related articles for article (PubMed ID: 28381470)

  • 1. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction.
    Koepp KE; Obokata M; Reddy YNV; Olson TP; Borlaug BA
    JACC Heart Fail; 2020 Aug; 8(8):657-666. PubMed ID: 32653449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
    Reddy YNV; Lewis GD; Shah SJ; Obokata M; Abou-Ezzedine OF; Fudim M; Sun JL; Chakraborty H; McNulty S; LeWinter MM; Mann DL; Stevenson LW; Redfield MM; Borlaug BA
    Mayo Clin Proc; 2019 Jul; 94(7):1199-1209. PubMed ID: 31272568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea.
    Kosyakovsky LB; Liu EE; Wang JK; Myers L; Parekh JK; Knauss H; Lewis GD; Malhotra R; Nayor M; Robbins JM; Gerszten RE; Hamburg NM; McNeill JN; Lau ES; Ho JE
    Circ Heart Fail; 2024 May; 17(5):e011366. PubMed ID: 38742409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Gorter TM; van Woerden G; Rienstra M; Dickinson MG; Hummel YM; Voors AA; Hoendermis ES; van Veldhuisen DJ
    JACC Heart Fail; 2020 Aug; 8(8):667-676. PubMed ID: 32653444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
    Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Reddy YNV; Obokata M; Testani JM; Felker GM; Tang WHW; Abou-Ezzeddine OF; Sun JL; Chakrabothy H; McNulty S; Shah SJ; Lewis GD; Stevenson LW; Redfield MM; Borlaug BA
    J Card Fail; 2020 Feb; 26(2):101-107. PubMed ID: 31618698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
    J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
    Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
    JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
    Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
    Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO
    Klaassen SHC; Liu LCY; Hummel YM; Damman K; van der Meer P; Voors AA; Hoendermis ES; van Veldhuisen DJ
    J Card Fail; 2017 Nov; 23(11):777-782. PubMed ID: 28736291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.
    Verbrugge FH; Omote K; Reddy YNV; Sorimachi H; Obokata M; Borlaug BA
    Eur Heart J; 2022 May; 43(20):1941-1951. PubMed ID: 35139159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.
    Obokata M; Kane GC; Reddy YN; Olson TP; Melenovsky V; Borlaug BA
    Circulation; 2017 Feb; 135(9):825-838. PubMed ID: 28039229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    Reddy YNV; Obokata M; Verbrugge FH; Lin G; Borlaug BA
    J Am Coll Cardiol; 2020 Sep; 76(9):1051-1064. PubMed ID: 32854840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.